MTOR and cancer: A wide array of subsequent studies confirmed the activating role of PD-L1 intrinsic signaling in the PI3K-AKT-mTOR pathways typically linked to enhancing cancer cell survival and resistance to apoptosis [99,100,101,102] (Figure 1).